Back to search

Article

Gene replacement therapy for Lafora disease in the <i> Epm2a <sup>-/-</sup> </i> mouse model

2023-12-14

Abstract excerpt

Lafora disease is a rare and fatal form of progressive myoclonic epilepsy typically occurring early in adolescence. Common symptoms include seizures, dementia, and a progressive neurological decline leading to death within 5-15 years from onset. The disease results from mutations transmitted with autosomal recessive inheritance in the EPM2A gene, encoding laforin, a dual-specificity phosphatase, or the EPM2B gen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c729cc0-a999-5115-8365-0762269cb6c1
DOI
10.1101/2023.12.14.571636
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gene replacement therapy for Lafora disease in the <i> Epm2a <sup>-/-</sup> </i> mouse modelDOI 10.1101/2023.12.14.571636
Select a neighboring publication to make it the new centre.